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Background: Apolipoprotein A-IV (apoA-IV) is a protein mainly synthesized by enterocytes in the intestine. Its gene
expression is suppressed during fasting and stimulated during active fat absorption. Chronic feeding of a high-fat (HF)
diet abolishes the differential expression between fasting and fat-feeding and therefore may contribute to diet-induced
obesity since apoA-IV is a potent satiety factor. It is well established that the circulating pro-inflammatory cytokines
TNF-α and IL-6 are increased by HF feeding.
Methods: To determine whether pro-inflammatory cytokines are involved in the diminished response of apoA-IV gene
expression to fat-feeding, different concentrations of linoleic acid (LA), an important dietary fatty acid, was used
to stimulate apoA-IV expression in human intestinal Caco2 cells. Cells were pre-treated with or without human
recombinant TNF-α, IL-6 or their combination before the addition of LA. Real-time PCR and ELISA were used to
detect and quantify RNA transcripts and proteins of apoA-IV and the cytokines.
Results: LA stimulated gene and protein expression of apoA-IV in a dose and time dependent manner. Pre-treatment
with the cytokines for 72 h significantly inhibited the increased expression of apoA-IV gene and protein induced by LA.
Furthermore, the cytokines, especially TNF-α, also positively up-regulate the cytokine themselves in Caco2 cells.
Conclusions: Our data indicate that the pro-inflammatory cytokines may be responsible for the reduced apoA-IV
production in response to fat feeding. Because of apoA-IV’s role in satiety, we propose the inhibitory effect of
circulating pro-inflammatory cytokines on apoA-IV production contributes to diet-induced obesity.
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Obesity has reached epidemic proportions globally, and
more than one-third of adults (35.7%) in USA are obese.
Being overweight or obese increases the risk of diseases
including cancer, coronary heart disease, type II diabetes,
hypertension and stroke. Compelling evidence has dem-
onstrated that dietary fat intake is a major cause of obesity,
diabetes, and the associated metabolic syndromes [1,2].
Human apoA-IV is a 46-kDa protein produced by
enterocytes of the small intestine and its production is
stimulated by fat absorption [3]. ApoA-IV is secreted in
association with triacylglycerol (TG) rich chylomicron* Correspondence: lzf2568@mail.xjtu.edu.cn
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dissociates from chylomicrons and then transfers into
high-density lipoproteins or becomes a lipoprotein-free
fraction of the plasma in the postprandial state [4].
ApoA-IV has a number of well-established functions, in-
cluding the inhibition of food intake, anti-inflammatory
role, reverse cholesterol transport, and the regulation
of glucose metabolism through the stimulation of insulin
secretion and inhibition of hepatic gluconeogenesis
[5-9]. Although the production of apoA-IV is stimulated
by fat absorption, chronic ingestion of high fat (HF)
feeding caused the adaptation of the intestinal apoA-IV
response to lipid feeding. Weinberg et al. [10] first re-
ported the adaptation of plasma apoA-IV in response to
chronic feeding of a HF diet in humans. They observed
that consumption of an HF diet for 1 week significantlyis an Open Access article distributed under the terms of the Creative Commons
rg/licenses/by/4.0), which permits unrestricted use, distribution, and
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HF diet, the apoA-IV level returned back to baseline.
Kalogeris and Painter [11] found that plasma apoA-IV
increased initially by 40% in response to intra-gastric
administration of fat emulsion within the first one
to two days, but this was followed by the diminished
responses with no increase in plasma apoA-IV levels
by four days of fat feeding. Similarly, the jejunal mRNA
levels and mucosal apoA-IV protein synthesis also
showed time-dependent refractoriness to fat administra-
tion, suggesting both posttranslational (protein clearance)
and/or pre-translation (transcriptional) adaptation of the
intestinal apoA-IV production.
It is well established that circulating pro-inflammatory
cytokines [e.g. tumor necrosis factor alpha (TNF-α),
interleukin 6 (IL-6)] are induced in obesity and these
pro-inflammatory cytokines play a crucial role in the
development of metabolic syndrome [12-14]. Ding et al.
reported that HF diet feeding and bacteria interaction
promoted TNF-α mRNA production and intestinal in-
flammation in mice; and the increase TNF-α preceded
obesity was strongly and significantly associated with
progression of obesity and development of insulin resist-
ance [15]. Recently, Ji et al. showed that intra-duodenal
infusion of fat emulsion caused mucosal mast cells activa-
tion and increased lymphatic secretion of pro-inflammatory
cytokines IL-6 [16]. These observations suggest that pro-
inflammatory cytokines derived from gut may contribute
to the development of obesity and associated metabolic
syndrome.
It was reported that treatment with cytokines TNF-α
or IL-6 in cultured pig hepatocytes decreased apoA-IV
mRNA levels [17], suggesting that the cytokines may
contribute to dietary-induced obesity through down-
regulation of the important satiety signal apoA-IV ex-
pression [18]. To determine whether pro-inflammatory
cytokines are involved in the attenuated response of
apoA-IV to chronic HF feeding, we performed in vitro
study to investigate the effect of human recombinant
cytokines TNF-α, IL-6 or their combination on apoA-IV
expression in response to the treatment of Linoleic acid
(LA, an important dietary fatty acid) in cultured human
intestinal Caco2 cells. Our results suggest that pro-
inflammatory cytokines inhibit apoA-IV production in-
duced by LA in Caco2 cells.
Methods
Materials
Linoleic acid, sodium taurocholate (TC) and other chemi-
cals were obtained from Sigma-Aldrich (St. Louis, MO,
USA). Recombinant human IL-6 (r-h-IL-6) and recombin-
ant human TNF-α (r-h-TNF-α) were purchased from
R&D Systems, Inc. (Minneapolis, MN, USA). Dulbecco’s
modified essential medium (DMEM), fetal bovine serum(FBS) and antibiotic: antimycotic mixture were obtained
from Thermo Fisher Scientific (Carlsbad, CA, USA).Cell cultures
Caco-2 cells, obtained from the American Type Culture
Collection (ATCC, Rockville, MD, USA), were grown
in DMEM containing high glucose, 20% FBS, and a
1% antibiotic: antimycotic mixture. 70-80% confluent
Caco-2 cells were plated onto 24-well plastic dishes
(Becton-Dickinson Labware, Lincoln Park, NJ, USA) at
initial densities of 1 × 105 cells/well in complete growth
medium. The medium was changed every other day for
14–21 days. This procedure is known to induce differenti-
ation of Caco-2 cells into more enterocyte-like cells [19].LA and cytokine treatment to Caco2 cells
To prepare LA stocks (20 ×), 20 mM LA and 10 mM
TC were mixed and stored at −20°C. To prepare TNF-α
and IL-6 (1000 ×, 10 mg/ml) stocks, r-h-IL-6 and r-h-
TNF-α were dissolved in phosphate buffered saline
(PBS). The differentiated Caco2 cells were incubated in
growth medium with or without 20 ng/ml TNF-α, or
20 ng/ml IL-6, respectively, or a mixture of the both
(20 ng/ml/each) for the indicated time, and then chan-
ged into DMEM/ high glucose/1% FBS with or without
indicated amount of LA: TC for the time indicated, with
0.5 mM TC as vehicle control. The cells were harvested
and lysed, and the total RNA was isolated.Real-time RT-PCR
Total RNA was isolated from cells with RNeasy Mini Kit
(Qiagen, Germantown, MD, USA). First-strand cDNA
was synthesized from 1 μg total RNA with Scripts™ cDNA
Synthesis Kit (Bio-Rad Laboratories Inc., Hercules, CA,
USA) according to the manufacturer’s instruction. Real-
time PCR was performed using iQ SYBR Green Supermix
(Bio-Rad Laboratories Inc. Hercules, CA, USA) with an
iCycler iQ Detection System (icycler iQ. Multicolor Real-
time PCR Detection System, Bio-Rad) and normalized to
β-actin. All primers were purchased from Integrated DNA
Technologies (Coralville, IA,USA). PCR primer pairs used
were: human apoA-IV forward, 5′-ACCCAGCTAAGCA
ACAATGC-3′, and reverse, 5′-TGTCCTGGAAGAGG
GTACTGA-3′; human Il6 forward, 5′-TGATGGATGCT
ACCAAACTGG-3′, and reverse, 5′-TTCATGTACTCCA
GGTAGCTATGG-3′; human Tnfα forward, 5′-TCTTC
TCATT CCTGCTTGTGG-3′, and reverse, 5′- GGTCT
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ELISA was performed using Human ApoA-IV ELISA Kit
from Millipore Corporation (Billerica, MA, USA), Human
IL-6 and Human TNF-α ELISA Kits from RayBiotech
(Norcross, GA, USA) according to the protocol provided
by the manufacturer. The culture mediums collected from
the cells treated with LA with or without cytokines were
used to measure the proteins released from the cells by
ELISA.
Statistics
Data represent Mean ± SE from three or four wells in
each experiment of at least two independent cell culture
experiments. Significance of differences was determined
by one-way ANOVA or two-way ANOVA followed by
Tukey test method. P value less than 0.05 was consid-
ered significant.
Results
LA stimulates apoA-IV gene expression in Caco2 cells
To induce gene expression of apoA-IV in Caco2 cells,
the medium of differentiated Caco2 cells was supple-
mented with LA mixed with TC in the indicated dose
and time, as described previously [19]. First, we studied
the effect of different concentrations (0.25, 0.5, 1.0 mM)
of LA on apoA-IV gene expression after 24 h incubation.
As shown in Figure 1A, 0.25 mM of LA was able to en-
hance apoA-IV gene expression by 1.31 fold, compared
with TC vehicle control, although there was no statisti-
cally significant difference. 0.5 mM of LA significantly
increased apoA-IV mRNA level by 3.3 fold, and 1 mM
of LA by 4.42 fold. Second, we determined the time
course of apoA-IV gene expression of Caco2 cells after
incubation with 1 mM LA for various times (3, 6, 12,
and 24 h). As shown in Figure 1B, apoA-IV mRNA level
started to increase by 2.34 fold when incubated with LA
for 12 h, and increased by 4.42 fold at 24 h, compared
with that treated with vehicle controls. Finally, to test
whether the apoA-IV protein is also changed with its
mRNA levels, we measured the apoA-IV protein levels
in the culture medium after the treatment with different
amount of LA for 24 h incubation. As presented in
Figure 1C, 0.25 mM LA surprisedly showed a maximum
effect on apoA-IV protein production, which was stron-
ger than 0.5 mM LA. However, when LA dose increased
to 1 mM, its effect on apoA-IV was almost gone. These
data indicate that LA up-regulates both apoA-IV mRNA
and protein levels in dose-dependent manner, but in dif-
ferent pattern, in the Caco2 cells.
Cytokines inhibit apoA-IV production induced by LA
It has been reported that cytokine IL-6 and TNF-α re-
duced apoA-IV mRNA levels in pig hepatocytes [17]. To
determine whether long time exposure to TNF-α andIL-6 also affects apoA-IV gene expression induced by LA
in Caco2 cells, the differentiated Caco2 cells were pre-
treated with r-h-TNFα and r-h-IL6 for 72 h, followed by
incubation with or without 1 mM LA for 24 h. As
shown in Figure 2A, the cytokines did not affect apoA-
IV mRNA in the cells without LA treatment. However,
pre-treatment with the combination of these two cyto-
kines significantly attenuated LA-induced increase of
mRNA levels (Figure 2A) and apoA-IV protein secretion
(Figure 2B). To further determine which cytokine, TNF-
α or IL-6, exerts the inhibitory effect, we pre-incubated
the cells with either TNF-α or IL-6, respectively,
followed by the LA treatment. We found that TNF-α
significantly attenuated the increased levels of both
apoA-IV mRNA (Figure 2A) and protein (Figure 2B) in-
duced by LA, whereas IL-6 had no such effect on apoA-
IV mRNA level (Figure 2A), but significantly attenuated
apoA-IV protein level induced by 0.25 mM LA (Figure 2B).
Furthermore, TNF-α and IL-6 themselves decreased
apoA-IV protein levels (Figure 2B), but not apoA-IV
mRNA levels (Figure 2A). These data indicate that both
TNF-α and IL-6 inhibit the stimulatory effect of LA on
apoA-IV production.
Effects of LA and cytokines on apoC-III gene expression in
Caco2 cells
ApoA-IV is a member of the apoA-I/C-III/A-IV gene
cluster. It was reported previously that intestinal expres-
sion of apoA-IV and apoC-III is coordinately regulated
by dietary lipid in newborn swine [20]. To test whether
LA specifically stimulates apoA-IV expression in Caco-2
cells, we measured the mRNA level of apoC-III in the
presence of LA or/and the cytokines, and determined
whether the pre-treatment of cytokines affects the re-
sponses of apoC-III to LA. As shown in Figure 2C, treat-
ment with 1 mM LA alone or pre-treatments with
cytokines (IL-6, TNF-α, or their combination) did not
significantly affect apoC-III gene expression in the Caco-
2 cells. Interestingly, TNF-α, but not IL-6, significantly
decreased apoC-III expression in the Caco-2 cells
(Figure 2C). These observations indicate that LA specif-
ically stimulates apoA-IV expression in Caco-2 cells. In
addition, different from the changes in apoA-IV mRNA
levels, apoC-III mRNA was significantly decreased by
TNF-α at the condition without LA stimulation.
LA stimulates productions of Il6 and Tnfα
It has been reported that long-chain fatty acid, e.g. the
LA, can enhance Il6 production in rat intestinal epithe-
lial cells [21]. To determine whether LA is able to affect
gene expressions of endogenous cytokines IL-6 and
TNF-α in the Caco2 cells, we measured mRNA levels of
Il6 and Tnfα at the indicated times of LA treatment
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Figure 1 LA induced apoA-IV gene expression in Caco2 cells.
Differentiated Caco2 cells were supplemented with or without
different amount of LA for 24 h (A) or for the indicated time with
1 mM LA (B) up to 24 h. The apoA-IV mRNA levels were measured
by real time RT-PCR. The levels of apoA-IV protein released into
culture medium from the cells were measured by ELISA (C).
***P <0.001 vs. TC vehicle control.
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24 h. We found that the LA stimulated Tnfα and Il6
gene expressions sooner than apoA-IV expression. The
mRNA level of Il6 started to increase by 1.03 fold after
3 h treatment, although the difference is not statistically
significant, and then reached to 3.4 fold increase at 6 h
(Figure 3A). The mRNA level of Tnfα was significantly
increased sooner than Il6 mRNA and it reached to 3.57
fold at 2 h, 3.52 fold increases at 3 h and then reduced
to 1.4 fold increases by 6 h (Figure 3B). It is noteworthy
that the pattern of Tnfα gene expression was similar to
Il6, and all dropped back to basal level at 12 h, but Il6 start
to express again at 24 h post-treatment of LA (Figure 4A),
which could be positive feedback regulation from the
other factors, such as TNF-α, as a result from LA stimula-
tion. We also measured their protein levels and found that
0.5 mM LA had the maximum effects on both IL-6 and
TNF-α protein levels although 0.25 mM and 1 mM LA in-
creased the cytokine protein productions, too (Figure 3C
and D).
Cytokines positively regulate their own gene expression
To determine whether the cytokines also affect their
own expression, the mRNAs of Il6 and Tnfα were mea-
sured in the Caco-2 cells treated with or without the
cytokines and/or with LA. As shown in Figure 4, no
change in Il6 mRNA levels was found in the cells when
these two cytokines were treated individually or their
combination without LA treatment. However, LA signifi-
cantly stimulated Il6 gene expression, which was signifi-
cantly attenuated by pre-treatment of IL-6, but not by
TNF-α. Additionally, pre-treatment with the combin-
ation of IL-6 and TNF-α led to further increase of Il6
gene expression in those cells. Similarly, treatment with
TNF-α, especially the combination of IL-6 and TNF-α,
stimulated Tnfα gene expression in the Caco-2 cells ei-
ther with or without LA treatment. These data indicate
that the cytokines, especially TNF-α, could positively
up-regulate their own gene expression in Caco-2 cells.
Discussion
ApoA-IV is produced dominantly in the gut and has
many physiological functions which include satiety,
regulation of glucose metabolism, reverse cholesterol
transport and also anti-inflammation [6,8,9,22]. There-
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Figure 2 Effects of cytokines on apoA-IV and apoC-III gene expression. (A) Effects of LA and cytokines on apoA-IV gene expression. Differentiated
Caco2 cells were pre-treated with or without r-h-TNF-α (20 ng/ml) or r-h-IL-6 (20 ng/ml) or the combination of these two cytokines for 72 h before
changing into medium with or without 1 mM LA for 24 h. (B) Effects of LA and cytokines on apoA-IV protein secretion. Differentiated Caco2 cells
were pre-treated with or without r-h-TNF-α (20 ng/ml) or r-h-IL-6 (20 ng/ml) or the combination of these two cytokines for 72 h before changing into
medium with or without 0.25 or 0.5 mM LA for 24 h. The apoA-IV proteins in culture medium secreted from the cells were measured by ELISA. (C)
Effects of LA and cytokines on apoC-III expression. The samples were processed at the same ways described at (A). The mRNA levels of both apoA-IV
and apoC-III were measured by real time RT-PCR. * P < 0.05, ** P < 0.01, *** P < 0.001 vs. vehicle control; and ##P < 0.01 ###P < 0.001 vs. LA.
Li et al. Journal of Inflammation  (2015) 12:22 Page 5 of 8active lipid absorption after chronic HF diet-feeding
has been implicated in the diet-induced obesity and
metabolic disorders. The purpose of this study was to
test the hypothesis that the inflammatory cytokines
expressed and released during chronic HF feeding po-
tentially play an important role in this reduced apoA-IV response to fat absorption. Linoleic acid (LA) is an
important dietary fatty acid and a major component
in many HF diets or the lipids that have been used to
induce apoA-IV production [11,23].
Caco-2 cells, a human colon carcinoma cell line, have
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Figure 3 LA stimulated gene expression of Il6 and Tnfα in Caco2 cells. Differentiated Caco2 cells were supplemented with or without 1 mM
LA for the indicated times for mRNA measurement or with different amount of LA for 24 h for protein measurement. The mRNA levels of Il6 and
Tnfα were measured by real time RT-PCR (A and B). Their proteins from culture medium were measured by ELISA (C and D). *P < 0.05, ** P <0.01,
*** P <0.001 vs. vehicle control.
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[19,24-27]. However, it has not been tested previously
whether LA stimulates apoA-IV expression in those
cells. With different dose of LA and varying incubation
times with the differentiated Caco2 cells, for the first
time, we found that apoA-IV gene expression and
protein secretion was significantly increased in re-
sponse to LA stimulation. Notably, apoA-IV produc-
tion was significantly enhanced with lower amount of
LA (0.25 mM) stimulation, but high dose of LA
(1 mM) failed to increase apoA-IV protein production,
although apoA-IV mRNA was significantly increased
with this amount of LA from 12 h to 24 h. It was well-
known that fat induces both apoA-IV synthesis and
secretion from the gut, but up to now, its molecular
mechanism is not clear. Our observations that apoA-
IV mRNA level was increased with the increase of LA
amount, but protein secretion of apoA-IV could not
induced by a higher amount of LA, indicating that
higher amount of LA may activate or induce other re-
lated factors, e.g. IL-6 and TNF-α, which can impact
apoA-IV’s translation and the stability.ApoA-IV is a member of a closely linked apoA-I/C-III/
A-IV gene cluster, a target for acute phase proteins. A
coordinately regulation of apoC-III and apoA-IV expres-
sion by lipids has been previously described [20]. How-
ever, it is also reported that the regulation of the
members of this cluster by fat and inflammatory pro-
cesses in the gut is not shared by all members of the
cluster, e.g. neither the magnitude of response to the
stimuli, nor the behavior of apoA-IV and apoC-III was
similar [17]. Our data showed no difference in apoC-III
gene expression in the cultured Caco2 cells treated with
LA, IL-6 or the both together. In contrast, significant
change in apoA-IV gene expression was observed when
the Caco2 cells were exposed to the same cytokines.
These results indicate a loss of the coordinated response
reported previously in the animals [20], and suggest a
complex interplay of transcription factors modulated by
species-specific signaling pathways in response to a spe-
cific stimuli.
Our data also showed that LA not only induced apoA-
IV gene expression, but also stimulated TNF-α and IL-6

































































































Figure 4 Effect of cytokines on gene expression of Il6 (A) and
Tnfα (B) in Caco2 cells. Differentiated Caco2 cells were pre-treated
with or without r-h-TNF-α (20 ng/ml), r-h-IL-6 (20 ng/ml) or their
combination for 72 h before changing into the medium with or
without LA (1 mM) for 24 h. The mRNA levels of both Il6 and Tnfα
were measured by real time RT-PCR. *P < 0.05, **P < 0.01, ***P < 0.001
vs. vehicle control; and #P <0.05, ###P <0.001 vs. LA.
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humans [28,29] and this could be reversed with weight
loss [30]. While the mechanisms underlying obesity-
associated inflammation are not fully understood, a
number of studies suggested that the inflammation may
derive from the accumulation of activated macrophages
within adipose tissue, liver, and the enlarged adipocytes
in obese animals and humans [14,31,32]. Recent studies
[15,16] suggest that 1) the gastrointestinal tract is an-
other and early source of inflammation associated with
diet, 2) the onset of intestinal inflammation precedes
diet-induced increases in body weight, fat mass, as well
as insulin resistance, and 3) the degree of TNF-α induc-
tion strongly correlates with diet-induced increases in
weight, adiposity, plasma glucose, and insulin. Our data
that LA-induced elevation of both TNF-α and IL-6
mRNAs and of protein levels in Caco2 cells furthersupport the concept that inflammatory cytokines re-
leased from the gut induced by fatty acid is the early
source of inflammation associated with the development
of obesity and/or metabolic disorders because TNF-α
and IL-6 are widely used as early biomarkers of inflam-
mation of insulin resistance and the obesity relative
diseases.
It has been reported that TNF-α activates NF-κB and
other inflammatory pathways [33,34]. As we described
above, LA not only induced apoA-IV gene expression
but also stimulated the gene expression and secretion of
the cytokines. In addition, consistent with previous stud-
ies, TNF-α and IL-6, especially TNF-α, are further stimuli
in the expression of the cytokines in the Caco2 cells, and
enhance the effect of LA on these cytokines.
It rapidly became clear that early proinflammatory
effects of HF diet, such as elevated TNF-α, could serve
as a trigger for subsequent inflammation or insulin resist-
ance through activating NF-kB and other inflammatory
pathways involved in the etiology of insulin resistance and
Type 2 diabetes. In addition to regulating metabolic
homeostasis and intracellular signaling pathways that are
well-established metabolic functions, inflammatory cyto-
kines can impact on release of gut hormones such as
glucagon-like peptide 2 (GLP-2) [15]. Our observations
that these two cytokines reduced apoA-IV production, but
not apoA-IV gene expression, imply that these cytokines’
inhibitory effects on apoA-IV not only occur at transcrip-
tional levels but also at translational or posttranslational
levels.
Pro-inflammatory molecules released by intestines,
adipose and liver enter the circulation to influence the
expression of apoA-IV at the gut. Our data that exogen-
ous cytokines decreased apoA-IV production induced by
LA support our hypothesis that pro-inflammatory cyto-
kines are involved in reducing apoA-IV responses to fat
feeding. These results support the notion that cytokines
induction by chronic fat feeding is responsible for the
blunted apoA-IV production normally stimulated by
active fat absorption.
Conclusions
Our study demonstrates that fatty acid LA induces
apoA-IV gene expression and, at the same time, pro-
motes inflammatory cytokines expression in the Caco2
cells. After chronic HF diet-feeding, constant and in-
creased cytokine release resulted from positive feed-
back regulation of the cytokines suppresses apoA-IV
production in response to fat absorption. Because of
apoA-IV’s roles in the regulation of food intake, lipid
absorption and glucose metabolism, the correlation
between the local/circulating pro-inflammatory cytokines
and apoA-IV production contributes to diet-induced
obesity and the associated disorders.
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